Valuation: LivaNova PLC

Market Cap 4.46B 3.98B 3.67B 3.33B 6.24B 423B 6.34B 44.23B 17.5B 221B 16.72B 16.37B 699B P/E 2026 *
20.2x
P/E 2027 * 24.4x
Enterprise Value 4.53B 4.05B 3.73B 3.39B 6.35B 430B 6.44B 44.97B 17.79B 225B 17B 16.64B 711B EV / Sales 2026 *
2.98x
EV / Sales 2027 * 2.68x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day-0.46%
1 week+3.06%
Current month+5.75%
1 month+3.07%
3 months+3.36%
6 months+24.12%
Current year+31.48%
1 week 77.39
Extreme 77.39
81.77
1 month 74.11
Extreme 74.11
81.77
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2024
Director of Finance/CFO 56 31/10/2020
Investor Relations Contact - 01/08/2022
Director TitleAgeSince
Director/Board Member 69 19/10/2015
Chairman 74 09/06/2021
Director/Board Member 62 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
9/15/26 A Free

General Counsel

6,291 0.0114%
9/10/26 A Sell

Director

-3,500 0.0064%
9/4/26 A Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%+3.06%+47.49%+63.73% 4.32B
+1.16%-0.94%-18.95%+7.15% 177B
-1.22%-0.04%-0.51%+31.24% 118B
+0.02%+4.75%-20.91%+15.60% 118B
+2.29%+21.86%-41.81%+11.12% 91.21B
-2.21%-3.05%+0.06%+75.36% 64.59B
-1.06%+4.59%+13.36%+78.58% 56.13B
-0.75%+2.66%+5.74%-23.09% 54.59B
-1.13%+2.41%-11.58%+31.24% 43.6B
+0.17%+5.12%-4.89%-10.48% 33.95B
Average -0.32%+4.15%-3.20%+28.05% 76.18B
Weighted average by Cap. -0.02%+3.55%-11.94%+22.47%

Financials

2026 *2027 *
Net sales 1.52B 1.36B 1.25B 1.14B 2.13B 144B 2.16B 15.1B 5.98B 75.63B 5.71B 5.59B 239B 1.63B 1.46B 1.34B 1.22B 2.28B 155B 2.32B 16.18B 6.4B 81B 6.12B 5.99B 256B
Net income 226M 202M 186M 169M 317M 21.48B 322M 2.25B 888M 11.24B 849M 831M 35.48B 187M 167M 154M 140M 262M 17.74B 266M 1.85B 734M 9.29B 701M 686M 29.31B
Net Debt 75M 66.96M 61.81M 56.09M 105M 7.12B 107M 744M 294M 3.73B 281M 275M 11.76B -85M -75.89M -70.05M -63.57M -119M -8.07B -121M -843M -334M -4.22B -319M -312M -13.33B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
23/10/26 $80.90 -0.46% 572,060
22/10/26 $81.27 +3.61% 522,978
21/10/26 $78.44 -1.59% 556,324
20/10/26 $79.71 +2.01% 583,802
19/10/26 $78.14 +0.72% 387,102
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
80.90USD
Average target price
90.55USD
Spread / Average Target
+11.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LivaNova PLC
  1. Stock Market
  2. Stocks
  3. LIVN Stock